Over careers that average over 32 years each in drug discovery and development within both Pharma, CRO and consulting sectors, the RDS consultants have been involved in most aspects of preclinical and clinical pharmacokinetics, drug metabolism and ADME studies from both logistic and strategic perspectives. This experience includes technical lab supervision, external study design, placement and monitoring, pharmacokinetic/ toxicokinetic data calculation and analysis, as well as preparation of project reports, regulatory documents (IND, NDA, package inserts), position papers, and literature summaries. In addition, they have published and presented widely in the areas of animal and human ADME, drug metabolism and drug interactions, pharmaceutical technology, pharmacokinetics and clinical research, medicinal chemistry, radiolabeled synthesis and bioanalysis.

Let our expertise in drug development both within Pharma and the CRO industry work for you!

Providing consulting services in the following areas:

• Human and animal pharmacokinetics (preclinical, Phase I and Phase II)
• Human and animal ADME/mass balance
• QA audits and qualification of ADME and bioanalytical labs
• GLP and non-GLP Toxicokinetic data analysis and reports
• In vivo/in vitro drug metabolism and drug interaction studies
• Drug Discovery ADME support
• Formulation Development support
• Method development and validation

RDS also provides general contract and consulting services in the following areas:

• Project/Study planning, placement and management
• Technical Report and Submissions Writing
• Due Diligence and Gap Analysis